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Requirement of Gai1/3–Gab1 Signaling Complex
for Keratinocyte Growth Factor–Induced
PI3K–AKT–mTORC1 Activation
Yi-ming Zhang1, Zhi-qing Zhang2, Yuan-yuan Liu2, Xin Zhou1, Xiao-hua Shi1, Qin Jiang3, Dong-li Fan1 and
Cong Cao2
Keratinocyte growth factor (KGF), also termed as fibroblast growth factor-7, promotes proliferation, migration,
and adhesion of skin keratinocytes via binding to keratinocyte growth factor receptor (KGFR) and subsequent
activation of downstream signaling including the PI3K-AKT-mTORC1 pathway. Here, we found that the
a-subunits of the G proteins (Gai1/3) and growth factor receptor binding 2-associated binding protein 1
(Gab1) are required for this activation process. With KGF stimulation, Gai1/3 formed a complex with KGFR and
was required for subsequent Gab1 recruitment, phosphorylation, and following PI3K-p85 activation. In addition,
Gai1/3 short hairpin RNA knockdown largely inhibited KGF-induced cell proliferation, migration, and the
accumulation of cyclin D1/fibronectin in cultured skin keratinocytes. Furthermore, we observed increased
expression of Gai1/3 in wounded human skin and keloid skin tissues, suggesting the possible involvement of
Gai1/3 in wound healing and keloid formation. Overall, we suggest that Gai1/3 proteins lie downstream of KGFR,
but upstream of Gab1-mediated activation of PI3KAKT-mTORC1 signaling, thus revealing a role for Gai proteins
in mediating KGFR signaling, cell migration, and possible wound healing.
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INTRODUCTION
Keratinocyte growth factor (KGF), also termed as fibroblast
growth factor-7 (FGF-7), belongs to the FGF family (Werner,
1998). KGF expression is relatively weak in normal skin.
However, it is significantly upregulated in skin fibroblasts
with a skin wound (Werner et al., 1992; Beer et al., 2000),
which regulates proliferation, differentiation, migration, and
adhesion of surrounding skin keratinocytes to facilitate wound
healing (Werner et al., 1992; Tsuboi et al., 1993; Werner et al.,
1994; Danilenko et al., 1995; Werner, 1998). Thus, dermal-
derived KGF regulates wound skin reepithelialization in a
paracrine manner. KGF regulates mitogenic effect by binding
to its receptor: keratinocyte growth factor receptor (KGFR), a
splicing transcript variant of the FGF receptor 2 (Shaoul et al.,
1995). KGFR is also a high-affinity receptor for fibroblast growth
factor-10 (FGF-10 or KGF-2) and fibroblast growth factor-1
(FGF-1; Miki et al., 1991; Igarashi et al., 1998).
KGFR is a cell surface receptor tyrosine kinase (RTK;
Ceridono et al., 2005). Following KGF binding, KGFR is
phosphorylated at multiple tyrosine residues in its
intracellular domain, providing docking sites of scaffold
proteins (i.e., phospholipase C-g and FGF receptor substrate
2 (FRS-2)) to activate downstream signaling pathways
including the mitogen-activated protein kinases (MAPKs) and
phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) signaling. Activation of these pathways
eventually mediates the effects of KGF on cell proliferation,
migration, differentiation, and survival (Shaoul et al., 1995;
Braun et al., 2006; Belleudi et al., 2011a, 2011b).
The heterotrimeric guanine nucleotide–binding proteins (G
proteins) of the Gai family of proteins, including Gai1, Gai2,
and Gai3, were originally identified by their ability to couple
to G protein–coupled receptors (GPCRs) and to inhibit
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adenylate cyclase (Alessi et al., 1997). Our previous study has
identified an unexpected role of Gai proteins in transducing
EGFR signaling (Cao et al., 2009). Gai1 and Gai3 are essential
for activation of PI3KAKT-mammalian mTOR complex 1
(mTORC1) signaling by the EGFR ligands. Upon EGF
stimulation, Gai proteins associate with EGFR and the
adaptor protein growth factor receptor binding 2-associated
binding protein 1 (Gab1) to mediate subsequent activation of
PI3K-AKT-mTORC1 signaling (Cao et al., 2009). Recently,
Wang et al. (2014) showed that Gai1/3 proteins differentially
regulate AKTmTORC1 and Erk1/2 activations in response to
different growth factors (Wang et al., 2014). Here, we show
that Gai1/3 and adaptor protein Gab1 are required for KGF-
induced activation of PI3K-AKT-mTORC1 signaling and are
important for keratinocyte migration and proliferation.
RESULTS
Gai proteins are required for the activation of AKT-mTORC1,
but not Erk, by KGFR family members in MEFs
To investigate the potential role of Gai1 and Gai3 in KGF-
induced activation of the AKT-mTORC1 pathway, we initially
utilized mouse embryonic fibroblasts (MEFs) derived from
wild-type (WT) or mouse embryos deficient in Gai1 and
Gai3 (termed double knockout (Gai1/3 DKO) cells; (Cao
et al., 2009). As there is no KGFR expression in regular
MEFs, we exogenously expressed KGFR into MEFs (MEFs/
KGFR, both WT and DKO) and generated stable cell lines (see
Materials and Methods). Reverse transcriptase–PCR and wes-
tern blotting results confirmed KGFR mRNA and protein
expression in stable MEFs (Figure 1a and b). Kinetic and
dose–response experiments demonstrated that MEFs/KGFR
lacking Gai1 and Gai3 were severely impaired in KGF-
induced AKT activation, which was detected by phosphoryla-
tion of AKT-308T, AKT-473S and GSK-3b (9S; Figure 1c and
Supplementary Figure S1 online).
We also tested the requirement of Gai proteins in the
activation of mTOR by KGF. Activated AKT phosphorylates
and inhibits TSC2, interfering with the ability of TSC2 to
inhibit mTORC1, leading to mTORC1 activation and 4E-BP1/
p70S6K1 (S6K) phosphorylation. We found that KGF-induced
mTORC1 activation, indicated by phosphorylation of 4E-BP1
(65S) and S6 (235/236S), was significantly inhibited by Gai1
and Gai3 deficiency (Figure 1d and ,Supplementary Figure S1
online). As expected, EGF-induced phosphorylation of AKT,
S6K, and S6 was abolished by Gai1 and Gai3 double knock-
outs (Figure 1c and d). To study the individual role of Gai1 or
Gai3 in the regulation of KGF-induced AKT-mTORC1 signal-
ing, Gai1 or Gai3 single-knockout MEFs were applied.
Similarly, KGFR was exogenously expressed into Gai1 or
Gai3 single-knockout MEFs. As demonstrated, KGF-induced
AKT-S6 phosphorylation was inhibited in the above single-
knockout MEFs/KGFR, whereas Gai1 and Gai3 DKO almost
abolished AKT-S6 phosphorylation by KGF (Figure 1e). Gai3
deficiency exerted more inhibitory effect on KGF-induced
AKT-S6 phosphorylation than did Gai1 deficiency (Figure 1e,
quantification). Note that the basal phosphorylation of the
above proteins was low and almost undetectable in the above
cell lines (data not shown). In contrast, loss of Gai1 and Gai3
had no effect on platelet-derived growth factor (PDGF)-BB-
induced phosphorylation of AKT (473S; Figure 1h). Signifi-
cantly, bFGF- and another KGFR ligand FGF-10-induced AKT
activation was also markedly inhibited in Gai1/3 DKO MEFs/
KGFR (Figure 1g).
To assess whether the defect in the activation of the AKT-
mTORC1 signaling by KGF in DKO MEFs/KGFR occurred at
the level of the receptor, we examined the expression and
activation of KGFR in the above MEFs. Activation of KGFR
was detected by measuring phosphorylation of KGFR and its
physiological substrate FRS-2 after KGF stimulation (Ceridono
et al., 2005). Results showed that KGFR and FRS-2 expression
in DKO MEFs/KGFR was equivalent to that of WT MEFs/KGFR
(Figure 1c and f). KGF-induced phosphorylation of KGFR (653/
654Y) and FRS-2 (196Y) was almost the same between WT
and DKO MEFs (Figure 1f), indicating that Gai proteins
possibly lie downstream of KGFR and FRS-2. A recent study
by Wang et al. (2014) demonstrated that Gai1/3 deficiency
impaired aFGF- and bFGF-induced phosphorylation of AKT
(S473) and S6 (S235/236) but not Erk1/2 (T202/Y204; Wang
et al., 2014). Here we found that KGF- and FGF-10-induced
Erk1/2 activation was not affected by Gai protein deficiency
(Figure 1e-g), indicating the selective requirement of Gai
proteins for activation of AKT-mTORC1 signaling by
KGFR family members. Together, these results suggest that
Gai1 and Gai3 proteins probably act downstream of the
KGFR-FRS-2 to regulate activation of AKT-mTORC1 by
KGF, FGF-10, and bFGF. Note that the expression of Gai2
in Gai1/3 DKO MEFs was lower than that in WT MEFs
(Figure 1g and h), and similar results were also seen in the
recent study (Wang et al., 2014).
Gai1 and Gai3 proteins are vital for the phosphorylation of
AKT-473S and S6 (65S) in response to KGF in KGFR-expressing
MEFs
To further rule out the possibility that the DKO MEFs/KGFR
behaved differently from WT MEFs/KGFR in response to
KGF, we verified these observations using RNA interference
(RNAi) and dominant-negative (DN) strategies (Cao et al.,
2009). Consistent with the above results, we observed that
combined knockdown of Gai1 and Gai3 in MEFs largely
inhibited the phosphorylation of AKT (473S) and GSK-3b
(9S), as well as 4E-BP1 (65S) and S6 (235/236S) by KGF.
Gai1 and Gai3 RNAis did not affect the expression or
phosphorylation of KGFR, FRS-2, or Erk (Figure 2a and b).
PDGF-BB-induced phosphorylation of AKT, S6K, S6, and Erk
was not affected by Gai1 and Gai3 RNAis (data not shown).
Significantly, we observed that reconstitution of WT-Gai3
into DKO MEFs/KGFR restored phosphorylation of AKT
(473S) and S6 (235/236S) in response to KGF (Figure 2c).
In contrast, the DN mutant Gai3 was not able to rescue
KGFR-induced AKT/S6 phosphorylation (Figure 2c). In this
DN Gai3 mutation, we substituted a conserved Gly(G)
residue with Thr (T) in the G3 box of Gai3 (Cao et al.,
2009). Gai3 with this mutation was unable to bind to
other proteins (Hubbard and Hepler, 2006; Barren
and Artemyev, 2007; Cao et al., 2009). Notably, KGFR
expression and phosphorylation after KGF stimulation were
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comparative in DKO MEFs/KGFR-expressing WT or mutant
Gai3 (Figure 2c), further confirming that Gai proteins lie
downstream of KGFR.
Notably, knockout of Gai2 had no significant effect on
KGF-induced phosphorylation of AKT-473S and AKT-308T
(Figure 2d). Pertussis toxin, which ADP-ribosylates Gai pro-
teins to interfere with GPCR-dependent signaling, also had no
effect on the AKT (473S) phosphorylation by KGF (Figure 2e).
Significantly, bFGF-/FGF-10-induced, but not PDGF-BB-
induced, AKT (473S) phosphorylation was inhibited by
 KGF
p-Akt s473
5′2′0′
WT Gαi1+3-DKO
5′2′0′
MEFs/KGFR
Akt
Erk1/2
p-Erk1/2
KGFR
p-KGFR
FRS2
p-FRS2
KGFR
EGFR
M
EF
s
M
EF
s/
KG
FR
-C
2
Ke
ra
tin
oc
yt
es
M
EF
s/
KG
FR
-C
1
β-Actin -45 kDa
-120 kDa
-175 kDa
20′10′5′0′
KGF (50 ng ml–1)
WT Gαi-1+3-DKO
MEFs/KGFR
20′10′5′0′
Gαi-1
Gαi-3
WT Gα
i-1
+3
-D
KO
EGF
p-Akt
s473
p-Akt
t308
p-GSK3β
s9
Akt
GSK3β
KGFR
Erk1/2
p-S6
s235/236
p-4E-BP1
s65
β-Actin
S6
p-Erk1/2
20′10′5′0′
KGF (50 ng ml–1)
WT Gαi-1+3-DKO
MEFs/KGFR
20′10′5′0′ WT Gα
i-1
+3
-D
KO
 EGF
bF
G
F
Gαi-3
Akt
p-Akt s473
p-Akt t308
Erk1/2
p-Erk1/2
FG
F-
10
bF
G
F
FG
F-
10
WT Gαi-1+3-DKO
MEFs/KGFR
Gαi-1
β-Actin
Gαi-2
0
0.5
1
p-Erk/
Erk
p-KGFR/
KGFR
WT
Gαi1+3-DKO
P >0.05
P >0.05
P >0.05
p-FRS2/
FRS2
p-Akt/
Akt
R
el
at
iv
e 
in
te
ns
ity
KGF (50 ng ml–1), 2′
*
0
0.2
0.4
0.6
0.8
1
Gαi3 SKO
Gαi1 SKO
Gαi1+3DKO
WT
R
el
at
iv
e 
in
te
ns
ity
p-Akt/Akt p-S6/S6
KGF (50 ng ml–1), 10′
*
*
*
*
*
*
#
#
#
#
0
1
2
3
4
5
bF
G
F
FG
F-
10
bF
G
F
FG
F-
10
P >0.05
P >0.05
WT
Gαi1+3-DKO
p-Erk/Erkp-Akt/Akt
*
*R
el
at
iv
e 
in
te
ns
ity
10′0′ 10′0′
WT Gαi-1+3-DKO
Gαi-1
Gαi-3
β-Actin
p-Akt s473
Akt
MEFs/KGFR
Gαi-2
PDGF
0
0.2
0.4
0.6
0.8
1
1.2
1.4 WT
Gαi1+3-DKO
R
el
at
iv
e 
in
te
ns
ity
p-Akt/Akt Gαi-2/Akt
*
P >0.05
PDGF, 10′
Gαi-1
p-Erk1/2
Erk1/2
Akt
S6
Gαi-3
KGFR
p-Akt s473
p-S6
G
α
i1
 K
O
G
α
i3
 K
O
G
α
i1
+3
-D
KO
W
T
KGF, 10′
MEFs/KGFR
M
EF
s
M
EF
s/
KG
FR
Ke
ra
tin
oc
yt
es
KGFR
GAPDH -983 bp
-1,019 bp
Figure 1. Gai1 and Gai3 are required for the activation of AKT-mTORC1 by keratinocyte growth factor (KGF) in mouse embryonic fibroblast (MEFs). (a) Wild
type (WT) MEFs were infected with virus particles containing keratinocyte growth factor receptor (KGFR)-pSUPER-puro-retro vector for 2 days, followed by
1.0mg ml1 of puromycin selection to generate KGFR-expressing MEFs (termed MEFs/KGFR), and KGFR and glyceraldehyde-3-phosphate dehydrogenase
mRNA expression was tested by reverse transcriptase–PCR. (b) KGFR, b-actin, and EGFR expression in MEFs, MEFs/KGFR (Clone-1/-2), and primary keratinocytes
were tested by western blotting. (c–h) WT MEFs/KGFR, Gai1 or Gai3 single-knockout (SKO) MEFs/KGFR, and Gai1/3 double knockout (DKO)-MEFs/KGFR
were treated with indicated KGF (50 ng ml 1), EGF (50 ng ml1, 10 min), fibroblast growth factor (FGF)-10 (25 ng ml1, 10 min), basic fibroblast growth
factor (bFGF) (25 ng ml1, 10 min), or platelet-derived growth factor (PDGF)-BB (25 ng ml1, 10 min), and listed proteins were analyzed by western blotting.
Indicated proteins or protein phosphorylation was quantified (for e–h; n¼3, same for all blot quantifications). *Po0.05. #Po0.05 versus Gai1/3 DKO MEFs/KGFR
group (e).
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Gai1/3 small interfering RNAs in MEFs/KGFR (Figure 2f). Our
observations confirm that Gai1 and Gai3 proteins have a vital
role in KGF-mediated activation of the AKT-mTORC1
signaling.
Gai proteins are required for the activation of AKT and mTORC1
by KGF in primary cultured skin keratinocytes
Using the lentiviral short hairpin RNA infection
strategy, we successfully generated stable Gai1 and Gai3
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double-knockdown keratinocytes. Results in Figure 3a showed
that expression of Gai1 and Gai3 was significantly down-
regulated in the stable keratinocytes. Gai1/3 knockdown did
not affect KGFR expression or KGF-induced KGFR phosphor-
ylation in keratinocytes (Figure 3a). However, KGF-induced
phosphorylation of AKT (473S) and S6 (235/236S) was largely
inhibited by Gai1/3 stable knockdown in keratinocytes,
although phosphorylation of Erk1/2 (202T/204Y) by KGF was
not significantly affected (Figure 3a). Thus, Gai1/3 depletion
only inhibited KGF-induced phosphorylation of AKT and S6,
but not KGFR or Erk. Next, we dissected the individual role of
Gai1 or Gai3 in KGF signaling in keratinocytes. Results
showed that stable depletion of Gai1 or Gai3 by single
lentiviral shRNA only alleviated KGF-induced AKT/S6 phos-
phorylation in primary keratinocytes, whereas combined
knockdown of Gai1 and Gai3 showed an additive inhibitory
effect on AKT/S6 phosphorylation (Supplementary Figure S2
online). Again, although both are required, Gai3 appears more
important than Gai1 in mediating AKT-mTORC1 activation by
KGF in primary keratinocytes (Supplementary Figure S2
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Figure 3. Gai1 and Gai3 proteins are required for keratinocyte growth factor (KGF)-induced AKT-mTOR complex 1 (mTORC1) activation in primary
keratinocytes. (a, e) KGF (50ng ml 1)-induced signaling in stable primary keratinocytes expressing scramble or Gai1/3 short hairpin RNAs or Gai2 short hairpin
RNA was tested. (b) Primary keratinocytes were introduced with anti-sense RNAs against Gai1/3 or scramble RNA sequence, and KGF (50 ng ml1)-induced
signaling was tested in the above cells. (c) KGF (50 ng ml1)-induced signaling in stable primary keratinocytes expressing empty vector or GFP-Tagged Gai1/3 was
detected. (d) KGF (50 ng ml 1, 10 min) or platelet-derived growth factor (PDGF)-BB (25ng ml1, 10 min)-induced AKT activation in stable primary keratinocytes
expressing empty vector or GFP-dominant-negative (DN)-Gai3 was shown. All protein phosphorylations in this figure were quantified. *Po0.05.
Figure 2. Gai1 and Gai3 proteins are vital for the phosphorylation of AKT (473 S) and S6 (235/236 S) in response to keratinocyte growth factor (KGF) in
keratinocyte growth factor receptor (KGFR)-expressing mouse embryonic fibroblast (MEFs). (a, b, f) Wild type (WT) MEFs/KGFR transfected with scramble small
interfering RNA or Gai1/3 small interfering RNAs were treated with KGF (50 ng ml1), basic fibroblast growth factor (bFGF) (25ng ml1), fibroblast growth factor
(FGF)-10 (25 ng ml1), or platelet-derived growth factor (PDGF)-BB (25 ng ml1) for 10 min, and western blotting was utilized to test indicated proteins.
(c) Double knockout (DKO) MEFs/KGFR were transfected with the vector encoding WT or dominant-negative (DN) Gai3 (G202T; 2mg each), and KGF
(50 ng ml1)-induced signaling in DKO MEFs (no KGFR, first two lanes) and above MEFs/KGFR (last four lanes) was tested. (d) KGF (50ng ml 1)-induced AKT
activation in WT and Gai2 KO MEFs/KGFR was treated. (e) WT MEFs were pretreated overnight with pertussis toxin (PTX, 100 ng ml1) followed by indicated KGF
treatment, and pAKT (473S) and AKT were detected by western blotting. Indicated proteins or protein phosphorylation was quantified. *Po0.05.
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Figure 4. Gab1, lying downstream of Gai, is required for keratinocyte growth factor (KGF)-induced AKT activation. (a, b) KGF (50ng ml1)-induced signaling in
keratinocyte growth factor receptor (KGFR)-expressing wild type (WT) or growth factor receptor binding 2-associated binding protein 1 (Gab1) KO mouse
embryonic fibroblast (MEFs) was detected by western blotting. (c) KGFR-expressing WT and Gai1/3 double knockout (DKO) MEFs were treated with KGF
(50 ng ml1), and pGab1 (627Y), Gab1, p-p85 (458Y), p85, and KGFR were tested. (d, e) KGF (50 ngml 1)-induced signaling in stable primary keratinocytes
expressing scramble or Gab1 short hairpin RNA was tested. (f) Stable primary keratinocytes expressing scramble or Gai1/3 short hairpin RNAs were treated with
KGF (50 ng ml1), and p-Gab1(627Y), Gab1, and Gai1 were tested. (g) Primary keratinocytes were treated with KGF (50 ngml1) for the indicated time, and the
association between Gai3, Gab1, and KGFR was tested by co-immunoprecipitation (Co-IP). (h) Stable primary keratinocytes expressing scramble or Gai1/3 short
hairpin RNAs were treated with KGF (50 ngml1) for 2 minutes, and expression and association of KGFR-FGF receptor substrate 2 (FRS-2)Gai3-Gab1 were
tested. All protein phosphorylations in this figure were quantified. *Po0.05.
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online, quantification). To further confirm the role of Gai1 and
Gai3 in KGFR signaling, the target small interfering RNAs
against Gai1 and Gai3 (targeting nonoverlapping mRNA
sequence with the plasmids) were utilized. These anti-sense
small interfering RNAs inhibited Gai1 and Gai3 expression
(460%) in primary keratinocytes. Further, KGF-induced
phosphorylation of AKT (473S) and S6 (235/236S), but not
Erk1/2, was markedly inhibited in Gai1/3-silenced cells
(Figure 3b).
In addition, we established a stable keratinocyte line
expressing WT-GFP-tagged Gai3 and WT-GFP-tagged Gai1.
KGF-induced AKT (473S) and S6 (235/236S) phosphorylation
was enhanced by the exogenous expression of wt-Gai1/3
(Figure 3c). On the other hand, overexpressing of the
DN mutant Gai3 inhibited KGF-induced AKT (473S)
phosphorylation, whereas AKT (473S) phosphorylation by
PDGF-BB was not affected (Figure 3d). These results further
confirmed that Gai1/3 proteins are required for the activation
of AKT and mTORC1 by KGF in keratinocytes. RNAi knocking
down of Gai2 had no significant effect on KGF-induced AKT
activation in keratinocytes (Figure 3e).
Gab1, lying downstream of Gai proteins, mediates KGF-induced
PI3K-AKT-mTORC1 activation
Upon RTK activation, Gab1 is enrolled in the plasma
membrane, being phosphorylated, and works as a scaffold to
mediate signal transduction from the receptor to downstream
events (Holgado-Madruga et al., 1996). We discovered that
Gab1 is associated with Gai proteins in response to EGFR
activation to transduce signaling from EGFR-Gai to p85 (Cao
et al., 2009). The role of Gab1 in KGFR signaling has not been
studied. As demonstrated, KGF induced Gab1 phosphory-
lation in MEFs/KGFR. Gab1 deficiency severely impaired
KGF-induced phosphorylation of AKT (473S), GSK-3b (9S),
and S6 (235/236S) in MEFs/KGFR (Figure 4a, upper panel and
Figure 4b), indicating that Gab1 is required for KGF-induced
AKT-mTORC1 activation. Importantly, KGF-induced p85
phosphorylation was also inhibited with Gab1 deficiency
(Figure 4a, lower panel and Figure 4b), indicating that
p85-PI3K activation by KGF requires Gab1.
To sort out the relationship between Gab1 and Gai in
mediating PI3K-AKT activation by KGF, we once again
utilized Gai1/3-deficient cells. KGF-induced phosphorylation
of Gab1 (627Y) and p85 (458Y) was almost abolished in
Gai1/3 DKO MEFs/KGFR (Figure 4c). In primary keratinocytes,
Gab1 depletion by shRNA inhibited KGF-induced AKT phos-
phorylation, whereas Gai1/3 protein expression was
unchanged (Figure 4d, left panel and Figure 4e). Significantly,
KGF-induced Erk1/2 and FRS-2 phosphorylation was not
affected by Gab1 shRNA knockdown in primary keratinocytes
(Figure 4d, right panel and Figure 4e). In primary keratino-
cytes, stable knockdown of Gai1/3 inhibited KGF-induced
Gab1 phosphorylation (Figure 4f). These results together
demonstrate that Gai1/3 proteins are upstream signals for
Gab1 in KGFR signaling. Co-immunoprecipitation results of
primary keratinocytes showed that KGFR, Gab1, and Gai3
formed a signaling complex after KGF stimulation (Figure 4g).
More importantly, Gai1/3 depletion by targeted shRNAs
largely inhibited KGF-induced KGFR-Gab1 association and
subsequent Gab1 phosphorylation, but leaving KGFR-FRS-2
association unaffected (Figure 4h). Expression of KGFR, Gab1,
and FRS-2 was not affected by Gai1/3 depletion (Figure 4h,
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Figure 5. Increased expression of Gai1/3 in human wounded skin and keloid skin tissues. (a, b) Gai1/Gai3 immunohistochemistry of the granulation tissue of
healing skin or surrounding healthy skin from the same patient (male, 35 years old, multiple skin wounds developing for 1 month). (c, d) Gai1/Gai3
immunohistochemistry of the skin keloid tissue and surrounding healthy skin tissue from the same patient (male, 27 years old, keloids develop for 4 months).
Similar results were seen in three independent patients. Bar¼ 100mm.
Y-m Zhang et al.
Gai1/3–Gab1 Complex Mediates KGF Signaling
www.jidonline.org 187
input). Consistent with these findings, Wang et al. (2014)
reported that bFGF induced Gai3 association with activated
FGF receptor and Gab1, whereas FRS-2-growth factor
receptor binding 2 association by bFGF was not affected by
Gai1/3 deficiency (Wang et al., 2014). On the basis of these
data, we propose that Gab1, lying downstream of FRS-2-Gai
proteins but upstream of PI3K-p85, mediates KGF-induced
AKT-mTORC1 activation.
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Figure 6. Gai proteins are important for keratinocyte growth factor (KGF)-dependent cell growth and migration in keratinocytes. Stable primary keratinocytes
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and cell proliferation and migration were detected by the BrdU incorporation assay (a), the /[H3] Thymidine DNA assay (b), and the ‘‘Transwell’’ assay (d), and
expression of Gai1, Gai3, and b-actin (c and e) as well as of cyclin D1 and fibronectin (f) in the above cells was tested by western blotting. (g) The proposed
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Increased expression of Gai1/3 in human wounded skin and
human keloid skin tissues
The above results suggest that Gai1/3 proteins are required for
KGF-induced AKT-mTORC1 activation in skin keratinocytes.
Next, we examined the expression of these two proteins in
different human skin tissues. Western blotting (Supplementary
Figure 3 S3 online) and immunohistochemistry (Figure 5a
and b) results showed that Gai1/3 expression was higher in
wounded human skin than in the surrounding normal skin
tissues, indicating a functional role of Gai proteins in wound
healing. Interestingly, Gab1 expression in the above-men-
tioned skin tissues was comparable (Supplementary Figure 3
S3 online). Skin keloid is characterized by excess accumula-
tion of collagen and hyperactivity of proliferation/migration of
skin cells within the wound (Singer and Clark, 1999). In these
conditions, hyperactivities of inflammations, synthesis and
secretion of extracellular matrix proteins (i.e., cytokines and
growth factors), and tissue remodeling have all been suggested
as pathological causes (Singer and Clark, 1999). As shown in
Figure 5c and d, a significant increase in Gai1 and Gai3
expression in keratinocytes of keloid skin was observed,
whereas expression of these two proteins was relatively low
in surrounding healthy skin tissues from the same individual.
Importantly, the expression of Gai1/3 in skin fibroblasts was
also higher in keloid skin than in surrounding non-lesional
skin (Figure 5c and d).
Gai proteins are important for KGF-dependent cell growth and
migration in keratinocytes
We next explored the biological role of Gai proteins in the
KGF signaling at the physiological level. We found that KGF-
induced cell proliferation was greatly alleviated in stable
keratinocytes expressing Gai-1/3 shRNA, and keratinocyte
proliferation was examined by BrdU incorporation assay
(Figure 6a) and the [H3] Thymidine assay (Figure 6b), and
expression of Gai1/3 and b-actin in stable cells is shown in
Figure 6c. In contrast, PDGF-BB-induced cell proliferation was
not affected by Gai1/3 depletions (Figure 6a and b).
In addition, stable knocking down of Gai1/3 by targeted
shRNAs largely inhibited KGF-induced keratinocyte migration
(Figure 6d), which was detected by the ‘‘Transwell’’ assay.
PDGF-BB-induced keratinocyte migration was independent of
Gai1/3 proteins (Figure 6d and e). Importantly, KGF-induced
upregulation of proliferation-associated protein cyclin D1 and
migration-associated protein fibronectin (Figure 6f) was almost
overturned by Gai1/3 lentiviral shRNA depletion in keratino-
cytes (Figure 6f). Taken together, our results demonstrate that
Gai proteins are critical for KGF-induced cyclin D1/fibronec-
tin expression, cell proliferation, and migration in primary
keratinocytes.
DISCUSSION
Studies have demonstrated a critical role of KGF-KGFR in the
wound healing process. The transgenic mice with a DN KGFR
mutation suffered a severe delay in wound healing (Werner
et al., 1994). Significant upregulation of KGF was seen in
mouse and human skin following skin wounds (Werner et al.,
1992; Beer et al., 2000). In the animal models of wound
healing, exogenous KGF markedly promoted wound reepithe-
lialization (Braun et al., 2002). In vitro, significant cell
migration and proliferation were seen in keratinocytes after
KGF stimulation, which was alleviated by the monoclonal
neutralizing antibody against KGFR (Tsuboi et al., 1993;
Danilenko et al., 1995).
KGF-KGFR binding induces receptor dimerization on the
cell surface with auto-phosphorylation of tyrosine residues
located in the cytosol (Shaoul et al., 1995; Heldin and
Ostman, 1996; Ceridono et al., 2005; Belleudi et al., 2011a,
2011b). Phosphorylated KGFR provides docking sites for Src
homology 2 domain–containing proteins, including Shc,
growth factor receptor binding 2, FRS-2, and PLC-g, to
mediate signal transduction (Heldin and Ostman, 1996). Our
IP data demonstrated that Gab1 and Gai proteins were recrui-
ted to KGFR after KGF stimulation and were required for
activation of downstream PI3K-AKT-mTORC1 signaling. Cells
with Gab1 deficiency showed defective PI3K-AKT-mTORC1
activation in response to KGF. Our data suggest that Gab1,
lying downstream of Gai proteins, mediates KGF-stimulated
PI3K-AKT-mTORC1 signaling transduction (Figure 6g).
Our results provide genetic evidence that Gai proteins are
critical for activation of the AKT-mTORC1 signaling by KGF.
Although we found that KGFR signaling and G proteins are
intertwined in the regulation of AKT-mTORC1 activation, little
is known about the precise molecular mechanisms that
regulate this cross talk. Growth factor receptors or RTKs are
known to activate G proteins through functional cross-talk
termed trans-activation (Marty and Ye, 2010). In that case,
activated RTKs trans-activate GPCR signaling through physical
association with Gai1/3 proteins, or through upregulation
of GPCR ligands (see discussion in Marty and Ye, (2010)).
This is unlikely the case here, as pertussis toxin, which
ADP-ribosylates the Gai family of proteins and uncouples
these G proteins from their GPCR receptors, had no effect on
KGF-induced AKT activation.
The present study reveals a unique mechanism for the role of
Gai proteins in KGFR signaling. We propose that, upon KGF
stimulation, Gai1 and Gai3 act downstream of KGFR-FRS-2 to
transduce KGFR signaling to Gab1, leading to Gab1 activation
and downstream p85-AKT-mTORC1 activation (Figure 6g).
Interestingly, loss of Gai2 did not result in a clear defect in
KGF-mediated AKT activation; this could be explained by the
fact that the expression of Gai1/3 in Gai2-deficient MEFs is
higher than that in WT cells ( see Cao et al., 2009). Intere-
stingly, mice with KGF knockout showed normal wound repair
(Guo et al., 1996), indicating that other members of the KGFR
family, i.e., FGF-10, could compensate the effect by KGF
(Igarashi et al., 1998; Jameson et al., 2002). In the current
study, we found that FGF-10- and bFGF-induced AKT and/or
mTORC1 activation was also dependent on Gai proteins.
Significantly, loss of Gai1 and Gai3 largely impaired KGF-
induced keratinocyte migration and proliferation. Because
PI3K-AKT-mTORC1 signaling is important for cell migration
and proliferation, this observation may be explained by a
failure of KGF to trigger the activation of this pathway in the
Gai-depleted cells. Interestingly, we found that keratinocytes
with Gai deficiency did not exhibit a defect in
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phosphorylation of Erk by KGF. Further, KGF-induced Erk
activation was intact in Gab1-deficient cells. Thus, the Gab1/
Gai signaling complex is not necessary for Erk activation by
KGF (Figure 6g). As a matter of fact, studies have shown that
KGFR-FRS-2 phosphorylation is required for Erk1/2 activation
by KGF (Ceridono et al., 2005). We found that KGF-stimulated
KGFR-FRS-2 phosphorylation and association were not
affected by Gai1/3 deficiency. Further, Wang et al. (2014)
showed that FRS-2-growth factor receptor binding 2
association, which mediates bFGF-induced Erk1/2 activation
(Kouhara et al., 1997), was also intact in Gai1/3 DKO MEFs
(Wang et al., 2014).
In summary, our results demonstrate that Gai1/3 proteins lie
downstream of KGFR, but upstream of Gab1-mediated activa-
tion of PI3K-AKT-mTORC1 signaling, thus revealing a role for
Gai proteins in mediating KGFR signaling, cell migration,
proliferation, and possible wound healing.
MATERIALS AND METHODS
The study was approved by the institutional review board of all
authors’ institutions. All clinical investigations were conducted
according to the principles expressed in the declaration of Helsinki.
Materials
Pertussis toxin was purchased from Sigma (Shanghai, China). KGF
(mouse and human), FGF-10, bFGF, EGF, and PDGF-BB were
purchased from Calbiochem (Shanghai, China).
Cell culture
WT, Gai1 or Gai3 single-knockout MEFs, Gai1 and Gai3 (Gai1/3)
DKO MEFs, as well as WT/Gab1-deficient MEFs were described
previously (Cao et al., 2009). Primary cultures of human keratinocytes
were gifts from Dr Bi’s Lab (Ji et al., 2012) and maintained in Medium
154-CF (Cascade Biologics, Portland, OR) supplemented with Human
Keratinocyte Growth Supplement (Cascade Biologics) plus antibiotics
and Ca2þ (0.03 mM; Cascade Biologics Invitrogen, Shanghai, China).
Cells were starved in 0.5% FBS medium overnight before any
treatment/s.
Exogenous expression of KGFR in MEFs
A complementary DNA encoding full-length human KGFR (from
primary keratinocytes; synthesized by GeneChem, Shanghai, China)
was sub-cloned into the pSUPER-puro-retro vector (Promega, Madi-
son, WI), which was then transfected into HEK-293 cells with
plasmids encoding viral packaging proteins VSVG and Hit-60
(Promega; Zecevic et al., 2009) using Lipofectamine 2000
(Invitrogen) reagent according to the manufacturer’s instructions.
Two days post transfection, the medium containing virus particles
was added to MEFs (both WT and KO MEFs), and infections were
allowed to proceed for 24 hours. The vector-expressing cells were
selected 10 days post infection in the presence of 1.0mg ml 1 of
puromycin. Expression of KGFR in the transfected MEFs (MEFs/KGFR)
was tested by western blotting and reverse transcriptase–PCR.
Generation of Gai1 and Gai3 stable knockdown keratinocytes
by lentiviral infection
Primary cultured skin keratinocytes were seeded in a six-well plate
with 60% confluence in a growth medium with polybrene. A quqntity
of 20ml ml 1 of lentiviral particles containing shRNA of human Gai1
(sc-105382-V) and/or human Gai3 (sc-29325-V; Santa Cruz Biotech,
Santa Cruz, CA) were added to the cells for 24 hours; the cell culture
medium was then replaced by growth medium, and cells were
cultured for an additional 24 hours. The stable clones expressing
target-shRNA/s were selected with puromycin (0.25mg ml 1, Sigma).
The culture medium was replaced with fresh puromycin-containing
culture medium every 2–3 days, until resistant colonies could be
identified (12–14 days). The expression of Gai1 and Gai3 protein in
stable cells was detected by western blotting. The same amount of
scramble nonsense shRNA lentiviral particles (Santa Cruz) was added
to the control cells. The Gab1 or Gai2 stable knockdown keratino-
cytes were generated similarly.
Gai plasmid transit transfection in MEFs
The expression vectors encoding EE-tagged Gai3 and EE-tagged DN
mutant of Gai3 (G202T) were described previously (Cao et al., 2009).
Plasmids were transfected with Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) according to the manufacturer’s recommendation.
After 24 hours, cells were starved before the indicated treatments.
Stable expression of Gai proteins in primary cultured
keratinocytes
The plasmid (0.25mg ml 1) encoding wt-Gai1 (Gai1-GFP-puro),
wt- Gai3 (Gai3-GFP-puro), and DN Gai3 (G202T; dominant-nega-
tive-Gai3-GFP-puro), were obtained from GeneChem (Shanghai,
China), or the empty vector (pGCL-GFP-puro, GeneChem) was
transfected to primary cultured skin keratinocytes with the Lipofecta-
mine 2000 as described. After 24 hours, cells were switched back to
culture medium for an additional 48 hours. Stable clones expressing
target plasmid were selected using puromycin (0.25mg ml 1) for 12–
14 days. The target protein (Gai-GFP) in stable cells was tested by
western blotting.
Western blotting, antibodies used, the co-Immunoprecipitation
assay,RNAi, the ‘‘Transwell’’ migration assay, reverse transcriptase–
PCR, and statistical analysis have been reported in Cao et al. (2009,
2013) and Chen et al. (2013), and are described in Supplementary
Information S1 online. The [H3] Thymidine incorporation assay and
the BrdU incorporation assay as well as immunohistochemistry
staining are also described in Supplementary Information S1 online.
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